1. Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis
   Stephanie B. Greene et al, 2016, PLOS ONE CrossRef
2. Androgen receptor in breast cancer: The “5W” questions
   Sara Ravaioli et al, 2022, Frontiers in Endocrinology CrossRef
3. ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer
   AbdulFattah Salah Fararjeh et al, 2019, International Journal of Molecular Sciences CrossRef
4. Papel de la activación adicional del gen RA en el desarrollo del fenotipo resistente a la castración en el cáncer de próstata
   P. Romão et al, 2022, Actas Urológicas Españolas CrossRef
5. Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines
   Stephen Wilson et al, 2016, Scientific Reports CrossRef
6. Androgen receptor in breast cancer: A wolf in sheep’s clothing? A lesson from prostate cancer.
   Samanta Salvi et al, 2020, Seminars in Cancer Biology CrossRef
7. Biomarkers of Castrate Resistance in Prostate Cancer: Androgen Receptor Amplification and T877A Mutation Detection by Multiplex Droplet Digital PCR
   Francis P. Young et al, 2022, Journal of Clinical Medicine CrossRef
8. Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancer
   Maija P. Valta et al, 2016, Clinical & Experimental Metastasis CrossRef
9. Additional activation of the AR gene may be involved in the development of the castration resistance phenotype in prostate cancer
   P. Romão et al, 2022, Actas Urológicas Españolas (English Edition) CrossRef
10. Androgen deprivation‑induced OPHN1 amplification promotes castration‑resistant prostate cancer
    Junjiang Liu et al, 2021, Oncology Reports CrossRef
11. Novel Insights into Molecular Indicators of Response and Resistance to Modern Androgen-Axis Therapies in Prostate Cancer
    John L. Silberstein et al, 2016, Current Urology Reports CrossRef
12. SUMO3 modification by PIAS1 modulates androgen receptor cellular distribution and stability
    Nanyang Yang et al, 2019, Cell Communication and Signaling CrossRef
13. Cellular growth factors as prospective therapeutic targets for combination therapy in androgen independent prostate cancer (AIPC)
    Bhavana Jonnalagadda et al, 2020, Life Sciences CrossRef
14. Pharmacotherapeutic strategies for castrate-resistant prostate cancer
    Mohamad Moussa et al, 2020, Expert Opinion on Pharmacotherapy CrossRef